Morgan Stanley Epizyme, Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 27, 2022
BUY
$0.42 - $1.48 $7,796 - $27,474
18,564 Added 2.27%
836,955 $1.23 Million
Q2 2022

Aug 15, 2022
BUY
$0.42 - $1.48 $7,796 - $27,474
18,564 Added 2.27%
836,955 $1.23 Million
Q1 2022

Oct 27, 2022
SELL
$1.06 - $2.68 $19,677 - $49,751
-18,564 Reduced 2.22%
818,391 $941,000
Q1 2022

May 13, 2022
BUY
$1.06 - $2.68 $31,832 - $80,483
30,031 Added 3.81%
818,391 $941,000
Q4 2021

Feb 14, 2022
SELL
$2.5 - $5.19 $4.8 Million - $9.97 Million
-1,920,113 Reduced 70.89%
788,360 $1.97 Million
Q3 2021

Nov 15, 2021
BUY
$4.82 - $8.46 $13.1 Million - $22.9 Million
2,708,473 New
2,708,473 $13.9 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email